The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.

Compare

45 Followers

Australian Clinical Labs Ltd (ACL) Ownership Overview

<0.01% Insiders

2.12% Mutual Funds

1.68% ETFs

96.19% Public Companies and

Individual Investors

The ownership structure of Australian Clinical Labs Ltd (AU:ACL) stock is a mix of institutional, retail, and individual investors. , <0.01% is owned by Insiders, and 96.19% is owned by Public Companies and Individual Investors.

The ownership structure of Australian Clinical Labs Ltd (AU:ACL) stock is a mix of institutional, retail, and individual investors. Approximately 3.80% of the company’s stock is owned by Institutional Investors, <0.01% is owned by Insiders, and 96.19% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date	Name	Activity	Value
Mar 05, 2024	Christine Nildra Bartlett Non Executive,director	xxxxxxxxxxxxx	AU$47154

Show More Insider Trading Activity >

Top Shareholders

# of Shares	Type	% Holding	Value
1,756,688	Institution	0.88%	4,182,674
1,724,780	Institution	0.86%	4,106,701
1,039,010	Institution	0.52%	2,473,883
727,472	Institution	0.36%	1,732,111
664,041	Institution	0.33%	1,581,082
558,964	Institution	0.28%	1,330,893
382,189	Institution	0.19%	909,992
231,040	Institution	0.12%	550,106
220,021	Institution	0.11%	523,870
217,855	Institution	0.11%	518,713

Top Mutual Fund Holders

# of Shares	Type	% Holding	Value
1,724,780	Institution	0.86%	4,106,701
1,039,010	Institution	0.52%	2,473,883
727,472	Institution	0.36%	1,732,111
664,041	Institution	0.33%	1,581,082
36,600	Institution	0.02%	87,145
31,607	Institution	0.02%	75,256
20,000	Institution	<0.01%	47,620
5,715	Institution	<0.01%	13,607
1,433	Institution	<0.01%	3,412

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
Vanguard FTSE Developed Markets ETF	1,124,663	Institution	0.56%	2,392,879
Vanguard FTSE All-World ex-US Small-Cap ETF	465,598	Institution	0.23%	990,625
SPDR S&P International Small Cap ETF	231,040	Institution	0.12%	532,563
WisdomTree International SmallCap Dividend Fund	230,444	Institution	0.11%	531,189
Dimensional International Core Equity 2 ETF	223,345	Institution	0.11%	514,824
Schwab International Small-Cap Equity ETF	220,021	Institution	0.11%	507,163
Dimensional International Small Cap ETF	218,221	Institution	0.11%	503,013
Avantis International Equity ETF	212,312	Institution	0.11%	492,532
Vanguard FTSE Pacific ETF	140,672	Institution	0.07%	299,299
WisdomTree Dynamic Currency Hedged International SmallCap Equity Fund	99,521	Institution	0.05%	229,403

FAQ

Who Owns Australian Clinical Labs Ltd (AU:ACL)?

Currently, no data Available

What percentage of Australian Clinical Labs Ltd (AU:ACL) stock is held by institutional investors?

Currently, no data Available

What percentage of Australian Clinical Labs Ltd (AU:ACL) stock is held by retail investors?

According to the latest TipRanks data, approximately 96.19% of Australian Clinical Labs Ltd (AU:ACL) stock is held by retail investors.

Who owns the most shares of Australian Clinical Labs Ltd (AU:ACL)?

Vanguard owns the most shares of Australian Clinical Labs Ltd (AU:ACL).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing